RGNX REGENXBIO Inc. gains 16% Nov 23, 2020
Developing gene therapies for rare diseases with a proprietary delivery platform.http://www.priceseries.com/trade/RGNX-REGENXBIO-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020110620201123.html